Symbols

CRVS

Corvus·NASDAQ

--(--)

CRVS Filings

2026-03-13 ·

Form 424B5 - Prospectus [Rule 424(b)(5)]

2026-03-13 ·

Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers

2026-03-13 · Key Events

Form 8-K - Current report

2026-03-12 · Earnings Call

Corvus Pharmaceuticals, Inc.(CRVS)-20260313-2025 Q4 Earnings call transcript

2026-03-12 · Financials

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

2026-03-12 · Key Events

Form 8-K - Current report

2026-02-13 ·

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

2026-02-05 ·

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

2026-01-30 · Ownership

Form 4 - Statement of changes in beneficial ownership of securities

2026-01-30 ·

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors